Frontlight ResearchEarly access
Trial site
Gangnam Severance Hospital, Yonsei University Health System
- 7running trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Alzheimer disease2 trials
- Lung cancer2 trials
- Lewy body dementia1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Pfizer2 trials
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Alzheimer disease1 recruiting
- Lewy body dementia1 recruiting
- Mild cognitive impairment1 recruiting
Site data: ClinicalTrials.govUpdated 19 Nov 2026